These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8988032

  • 1. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples.
    Sun Y, Lin J, Katz AE, Fisher PB.
    Cancer Res; 1997 Jan 01; 57(1):18-23. PubMed ID: 8988032
    [Abstract] [Full Text] [Related]

  • 2. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.
    Shen R, Su ZZ, Olsson CA, Fisher PB.
    Proc Natl Acad Sci U S A; 1995 Jul 18; 92(15):6778-82. PubMed ID: 7542776
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG, Raj GV, Moreno JG.
    J Urol; 1997 Aug 18; 158(2):326-37. PubMed ID: 9224297
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Deconstructing PTI-1: PTI-1 is a truncated, but not mutated, form of translation elongatin factor 1A1, eEF1A1.
    Mansilla F, Hansen LL, Jakobsen H, Kjeldgaard NO, Clark BF, Knudsen CR.
    Biochim Biophys Acta; 2005 Feb 14; 1727(2):116-24. PubMed ID: 15716006
    [Abstract] [Full Text] [Related]

  • 7. Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
    Su Z, Goldstein NI, Fisher PB.
    Proc Natl Acad Sci U S A; 1998 Feb 17; 95(4):1764-9. PubMed ID: 9465091
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma.
    Wang-Johanning F, Frost AR, Jian B, Azerou R, Lu DW, Chen DT, Johanning GL.
    Cancer; 2003 Jul 01; 98(1):187-97. PubMed ID: 12833471
    [Abstract] [Full Text] [Related]

  • 10. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
    Anastasiadis AG, Ghafar MA, Salomon L, Vacherot F, Benedit P, Chen MW, Shabsigh A, Burchardt M, Chopin DK, Shabsigh R, Buttyan R.
    J Cancer Res Clin Oncol; 2002 Jul 01; 128(7):358-62. PubMed ID: 12136249
    [Abstract] [Full Text] [Related]

  • 11. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
    Slawin KM, Shariat SF, Nguyen C, Leventis AK, Song W, Kattan MW, Young CY, Tindall DJ, Wheeler TM.
    Cancer Res; 2000 Dec 15; 60(24):7142-8. PubMed ID: 11156423
    [Abstract] [Full Text] [Related]

  • 12. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A, Sood AK.
    Clin Cancer Res; 2001 Sep 15; 7(9):2731-8. PubMed ID: 11555586
    [Abstract] [Full Text] [Related]

  • 13. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
    Gao CL, Dean RC, Pinto A, Mooneyhan R, Connelly RR, McLeod DG, Srivastava S, Moul JW.
    J Urol; 1999 Apr 15; 161(4):1070-6. PubMed ID: 10081840
    [Abstract] [Full Text] [Related]

  • 14. Translational infidelity and human cancer: role of the PTI-1 oncogene.
    Gopalkrishnan RV, Su ZZ, Goldstein NI, Fisher PB.
    Int J Biochem Cell Biol; 1999 Jan 15; 31(1):151-62. PubMed ID: 10216950
    [Abstract] [Full Text] [Related]

  • 15. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.
    Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw DR, Strong TV.
    Clin Cancer Res; 2001 Jun 15; 7(6):1553-60. PubMed ID: 11410490
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
    Ko J, Lee YH, Hwang SY, Lee YS, Shin SM, Hwang JH, Kim J, Kim YW, Jang SW, Ryoo ZY, Kim IK, Namkoong SE, Kim JW.
    Oncogene; 2003 Jul 24; 22(30):4679-89. PubMed ID: 12879013
    [Abstract] [Full Text] [Related]

  • 18. Scanning copy number and gene expression on the 18q21-qter chromosomal region by the systematic multiplex PCR and reverse transcription-PCR methods.
    Yamamoto F, Yamamoto M.
    Electrophoresis; 2007 Jun 24; 28(12):1882-95. PubMed ID: 17523142
    [Abstract] [Full Text] [Related]

  • 19. High expression of a new marker PCA-1 in human prostate carcinoma.
    Konishi N, Nakamura M, Ishida E, Shimada K, Mitsui E, Yoshikawa R, Yamamoto H, Tsujikawa K.
    Clin Cancer Res; 2005 Jul 15; 11(14):5090-7. PubMed ID: 16033822
    [Abstract] [Full Text] [Related]

  • 20. Neurofilament heavy chain-like messenger RNA and protein are present in benign prostate and down-regulated in prostatic carcinoma.
    Schleicher RL, Hunter SB, Zhang M, Zheng M, Tan W, Bandea CI, Fallon MT, Bostwick DG, Varma VA.
    Cancer Res; 1997 Aug 15; 57(16):3532-6. PubMed ID: 9270025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.